HNRNPAB | OmnibusX

I. Expression across cell types

Name	Number of supported studies	Average coverage
endothelial cell	24 studies	28% ± 10%	Explore
conventional dendritic cell	23 studies	28% ± 16%	Explore
B cell	21 studies	23% ± 6%	Explore
natural killer cell	21 studies	27% ± 12%	Explore
fibroblast	20 studies	30% ± 12%	Explore
pericyte	19 studies	28% ± 11%	Explore
smooth muscle cell	19 studies	28% ± 8%	Explore
macrophage	17 studies	26% ± 8%	Explore
epithelial cell	17 studies	37% ± 17%	Explore
CD8-positive, alpha-beta T cell	16 studies	29% ± 15%	Explore
T cell	15 studies	27% ± 10%	Explore
plasmacytoid dendritic cell	15 studies	28% ± 9%	Explore
basal cell	15 studies	34% ± 14%	Explore
non-classical monocyte	12 studies	25% ± 9%	Explore
CD4-positive, alpha-beta T cell	12 studies	31% ± 18%	Explore
regulatory T cell	12 studies	26% ± 14%	Explore
endothelial cell of lymphatic vessel	11 studies	31% ± 9%	Explore
classical monocyte	11 studies	25% ± 12%	Explore
connective tissue cell	11 studies	26% ± 8%	Explore
endothelial cell of vascular tree	10 studies	30% ± 13%	Explore
gamma-delta T cell	10 studies	29% ± 16%	Explore
dendritic cell	9 studies	32% ± 18%	Explore
CD16-positive, CD56-dim natural killer cell, human	9 studies	22% ± 5%	Explore
ciliated cell	9 studies	34% ± 18%	Explore
mast cell	8 studies	26% ± 11%	Explore
monocyte	8 studies	27% ± 10%	Explore
CD8-positive, alpha-beta memory T cell	8 studies	26% ± 7%	Explore
secretory cell	8 studies	35% ± 15%	Explore
endothelial cell of artery	8 studies	25% ± 6%	Explore
plasmablast	7 studies	50% ± 22%	Explore
abnormal cell	7 studies	28% ± 10%	Explore
goblet cell	7 studies	29% ± 9%	Explore
vein endothelial cell	7 studies	30% ± 12%	Explore
myofibroblast cell	7 studies	30% ± 11%	Explore
myeloid cell	7 studies	34% ± 15%	Explore
hematopoietic precursor cell	6 studies	50% ± 17%	Explore
plasma cell	6 studies	32% ± 20%	Explore
CD4-positive, alpha-beta memory T cell	6 studies	21% ± 4%	Explore
respiratory goblet cell	6 studies	28% ± 13%	Explore
effector CD8-positive, alpha-beta T cell	6 studies	31% ± 13%	Explore
CD16-negative, CD56-bright natural killer cell, human	6 studies	28% ± 6%	Explore
mucosal invariant T cell	6 studies	19% ± 3%	Explore
capillary endothelial cell	6 studies	28% ± 13%	Explore
neuron	6 studies	33% ± 17%	Explore
innate lymphoid cell	6 studies	24% ± 8%	Explore
memory B cell	6 studies	27% ± 10%	Explore
club cell	5 studies	26% ± 10%	Explore
leukocyte	5 studies	34% ± 11%	Explore
naive B cell	5 studies	24% ± 6%	Explore
mononuclear phagocyte	5 studies	25% ± 10%	Explore
effector memory CD8-positive, alpha-beta T cell	5 studies	26% ± 9%	Explore
transit amplifying cell	5 studies	40% ± 15%	Explore
pro-B cell	5 studies	31% ± 16%	Explore
type I pneumocyte	4 studies	28% ± 7%	Explore
type II pneumocyte	4 studies	28% ± 12%	Explore
deuterosomal cell	4 studies	46% ± 12%	Explore
naive thymus-derived CD4-positive, alpha-beta T cell	4 studies	26% ± 5%	Explore
mature NK T cell	4 studies	29% ± 6%	Explore
erythroblast	4 studies	61% ± 24%	Explore
hematopoietic stem cell	4 studies	38% ± 19%	Explore
precursor B cell	4 studies	33% ± 17%	Explore
progenitor cell	4 studies	44% ± 17%	Explore
effector memory CD4-positive, alpha-beta T cell	4 studies	30% ± 12%	Explore
luminal hormone-sensing cell of mammary gland	4 studies	33% ± 12%	Explore
megakaryocyte-erythroid progenitor cell	4 studies	63% ± 21%	Explore
alveolar macrophage	3 studies	18% ± 2%	Explore
precursor cell	3 studies	53% ± 14%	Explore
pancreatic A cell	3 studies	33% ± 10%	Explore
naive thymus-derived CD8-positive, alpha-beta T cell	3 studies	28% ± 6%	Explore
intestinal crypt stem cell	3 studies	28% ± 12%	Explore
neural crest cell	3 studies	37% ± 3%	Explore
extravillous trophoblast	3 studies	25% ± 4%	Explore
placental villous trophoblast	3 studies	32% ± 9%	Explore
lymphocyte	3 studies	44% ± 8%	Explore
brush cell	3 studies	30% ± 19%	Explore
oligodendrocyte precursor cell	3 studies	24% ± 2%	Explore
enteroendocrine cell	3 studies	32% ± 8%	Explore
T follicular helper cell	3 studies	18% ± 3%	Explore
erythrocyte	3 studies	56% ± 28%	Explore
group 3 innate lymphoid cell	3 studies	36% ± 14%	Explore
keratinocyte	3 studies	35% ± 11%	Explore
T-helper 17 cell	3 studies	34% ± 21%	Explore
progenitor cell of mammary luminal epithelium	3 studies	23% ± 7%	Explore

II. Expression across tissues

Name	Number of supported studies	Average coverage
lung	12 studies	29% ± 12%	Explore
intestine	9 studies	25% ± 9%	Explore
uterus	6 studies	29% ± 15%	Explore
liver	6 studies	29% ± 18%	Explore
peripheral blood	5 studies	34% ± 8%	Explore
kidney	4 studies	17% ± 1%	Explore
lymph node	4 studies	27% ± 15%	Explore
breast	4 studies	30% ± 12%	Explore
pancreas	3 studies	34% ± 13%	Explore
placenta	3 studies	24% ± 6%	Explore
ovary	3 studies	21% ± 5%	Explore
prostate	3 studies	32% ± 6%	Explore
brain	3 studies	22% ± 5%	Explore
bone marrow	3 studies	31% ± 8%	Explore

Tissue	GTEx Coverage	GTEx Average TPM	GTEx Number of samples	TCGA Coverage	TCGA Average TPM	TCGA Number of samples
esophagus	100%	6725.21	1445 / 1445	100%	255.60	183 / 183
intestine	100%	7404.48	966 / 966	100%	363.32	527 / 527
skin	100%	8230.96	1809 / 1809	100%	246.07	472 / 472
stomach	100%	4834.06	359 / 359	100%	323.80	286 / 286
lung	100%	5768.30	577 / 578	100%	207.91	1154 / 1155
uterus	100%	5088.75	170 / 170	100%	296.54	457 / 459
ovary	100%	4379.39	180 / 180	100%	230.39	428 / 430
bladder	100%	6443.38	21 / 21	99%	270.69	501 / 504
breast	100%	5239.09	459 / 459	99%	264.67	1111 / 1118
prostate	100%	5164.22	245 / 245	99%	187.64	498 / 502
thymus	100%	4613.49	652 / 653	99%	159.09	599 / 605
kidney	100%	4994.40	89 / 89	98%	134.46	883 / 901
adrenal gland	100%	7695.19	258 / 258	97%	131.45	224 / 230
liver	100%	3948.03	226 / 226	97%	124.64	395 / 406
pancreas	97%	2470.02	319 / 328	99%	191.64	176 / 178
brain	96%	2241.56	2538 / 2642	100%	151.59	703 / 705
adipose	100%	5853.11	1204 / 1204	0%	0	0 / 0
eye	0%	0	0 / 0	100%	208.60	80 / 80
lymph node	0%	0	0 / 0	100%	340.88	29 / 29
spleen	100%	6410.80	241 / 241	0%	0	0 / 0
tonsil	0%	0	0 / 0	100%	288.34	45 / 45
ureter	0%	0	0 / 0	100%	84.23	1 / 1
blood vessel	100%	4373.29	1334 / 1335	0%	0	0 / 0
muscle	100%	5547.24	802 / 803	0%	0	0 / 0
heart	98%	3969.96	845 / 861	0%	0	0 / 0
peripheral blood	86%	4377.51	802 / 929	0%	0	0 / 0
abdomen	0%	0	0 / 0	0%	0	0 / 0
bone marrow	0%	0	0 / 0	0%	0	0 / 0
diaphragm	0%	0	0 / 0	0%	0	0 / 0
gingiva	0%	0	0 / 0	0%	0	0 / 0
nasal cavity	0%	0	0 / 0	0%	0	0 / 0
nasopharynx	0%	0	0 / 0	0%	0	0 / 0
nose	0%	0	0 / 0	0%	0	0 / 0
placenta	0%	0	0 / 0	0%	0	0 / 0
spinal column	0%	0	0 / 0	0%	0	0 / 0

III. Associated gene sets

GO_0010468	Biological process	regulation of gene expression
GO_0001837	Biological process	epithelial to mesenchymal transition
GO_0016556	Biological process	mRNA modification
GO_2000623	Biological process	negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay
GO_0045893	Biological process	positive regulation of DNA-templated transcription
GO_0090575	Cellular component	RNA polymerase II transcription regulator complex
GO_0005654	Cellular component	nucleoplasm
GO_1990904	Cellular component	ribonucleoprotein complex
GO_0000785	Cellular component	chromatin
GO_0045293	Cellular component	mRNA editing complex
GO_0005737	Cellular component	cytoplasm
GO_0005634	Cellular component	nucleus
GO_0005515	Molecular function	protein binding
GO_0003729	Molecular function	mRNA binding
GO_0003723	Molecular function	RNA binding

IV. Literature review

[source]

Gene name	HNRNPAB
Protein name	Heterogeneous nuclear ribonucleoprotein A/B (hnRNP A/B) (APOBEC1-binding protein 1) (ABBP-1) Heterogeneous nuclear ribonucleoprotein A/B
Synonyms	HNRPAB ABBP1
Description	FUNCTION: Binds single-stranded RNA. Has a high affinity for G-rich and U-rich regions of hnRNA. Also binds to APOB mRNA transcripts around the RNA editing site.
Accessions	D6RBZ0 ENST00000514633.5 ENST00000506259.5 [Q99729-3] Q99729 ENST00000358344.8 [Q99729-2] D6R9P3 ENST00000506339.5 D6RD18 ENST00000515193.5 ENST00000504898.5 [Q99729-2] ENST00000355836.9 [Q99729-3]

HNRNPAB report

I. Expression across cell types

II. Expression across tissues

III. Associated gene sets

IV. Literature review